Microbial double-stranded DNA (dsDNA)

Microbial double-stranded DNA (dsDNA) in anaerobic and microaerophilic organisms serves as the primary molecular target for the nitroimidazole class of anti-infective agents [StatPearls: Metronidazole, 2023]. These drugs act as prodrugs that require a low-redox potential environment to undergo reductive activation, typically mediated by microbial electron transport proteins such as ferredoxin or flavodoxin [PubMed: PMC185238]. Once reduced, the drugs form highly reactive nitro radical anions and other short-lived intermediates that interact directly with the microbial DNA [PubChem: CID 4173]. This interaction results in the formation of covalent adducts, single- and double-strand breaks, and the loss of the DNA helical structure, which collectively inhibit nucleic acid synthesis and lead to rapid cell death [NIH: LiverTox, Metronidazole]. This mechanism provides high selectivity for anaerobic bacteria (e.g., Bacteroides, Clostridioides) and certain protozoa (e.g., Trichomonas, Giardia, Entamoeba) because aerobic host cells lack the necessary low-redox potential to activate the drug [Wikipedia: Metronidazole].

Other names

Bacterial DNAProtozoal DNAGenomic DNAMicrobial dsDNA

Reductive activation of nitroimidazole prodrugs in anaerobic environments generates reactive nitro radical anions that cause covalent binding, strand breakage, and helix destabilization of microbial DNA.